Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1431316rdf:typepubmed:Citationlld:pubmed
pubmed-article:1431316lifeskim:mentionsumls-concept:C0079460lld:lifeskim
pubmed-article:1431316lifeskim:mentionsumls-concept:C0600531lld:lifeskim
pubmed-article:1431316lifeskim:mentionsumls-concept:C0002199lld:lifeskim
pubmed-article:1431316lifeskim:mentionsumls-concept:C0312418lld:lifeskim
pubmed-article:1431316lifeskim:mentionsumls-concept:C0441472lld:lifeskim
pubmed-article:1431316lifeskim:mentionsumls-concept:C0036667lld:lifeskim
pubmed-article:1431316lifeskim:mentionsumls-concept:C1521805lld:lifeskim
pubmed-article:1431316pubmed:issue5lld:pubmed
pubmed-article:1431316pubmed:dateCreated1992-12-22lld:pubmed
pubmed-article:1431316pubmed:abstractTextThree variants of the human monoblastic cell line U937 with different degrees of sensitivity to the antiproliferative action of interferon-alpha (IFN-alpha were examined for phenotypic differences. The highly IFN-sensitive variant U937-V expressed twice as many IFN-alpha binding sites as both its IFN-alpha-resistant derivative U937-VR and the cell line U937 exhibiting a 20-fold reduction in IFN-alpha sensitivity as compared to U937-V cells. All three variants were IFN-reactive with regard to induction of 2',5'-oligoadenylate (2-5A) synthetase activity and were similarly sensitive to the growth-inhibiting action of IFN-gamma and tumor necrosis factor. Responsiveness to the antiproliferative effect of granulocyte-macrophage colony-stimulating factor (GM-CSF), however, was confined to cell lines U937 and U937-VR. Although expressing a comparable number of GM-CSF receptors, the highly IFN-sensitive variant U937-V was refractory to GM-CSF. Flow cytometry revealed a marked difference in the expression of the antigen CD11b which was detectable on 85% of cells of the U937-V line but only on approximately 25% of cells derived from the U937 and U937-VR lines. Results thus demonstrate opposite sensitivity of U937 cells to the growth-inhibiting action of IFN-alpha and GM-CSF, apparently dependent on the state of U937 differentiation as determined by expression of the CD11b antigen.lld:pubmed
pubmed-article:1431316pubmed:languageenglld:pubmed
pubmed-article:1431316pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1431316pubmed:citationSubsetIMlld:pubmed
pubmed-article:1431316pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1431316pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1431316pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1431316pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1431316pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1431316pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1431316pubmed:statusMEDLINElld:pubmed
pubmed-article:1431316pubmed:monthOctlld:pubmed
pubmed-article:1431316pubmed:issn0197-8357lld:pubmed
pubmed-article:1431316pubmed:authorpubmed-author:RosePPlld:pubmed
pubmed-article:1431316pubmed:authorpubmed-author:MoritaMMlld:pubmed
pubmed-article:1431316pubmed:authorpubmed-author:SeeberSSlld:pubmed
pubmed-article:1431316pubmed:authorpubmed-author:LEVYJ PJPlld:pubmed
pubmed-article:1431316pubmed:authorpubmed-author:NiederleNNlld:pubmed
pubmed-article:1431316pubmed:authorpubmed-author:KummerGGlld:pubmed
pubmed-article:1431316pubmed:authorpubmed-author:KlokeOOlld:pubmed
pubmed-article:1431316pubmed:issnTypePrintlld:pubmed
pubmed-article:1431316pubmed:volume12lld:pubmed
pubmed-article:1431316pubmed:ownerNLMlld:pubmed
pubmed-article:1431316pubmed:authorsCompleteYlld:pubmed
pubmed-article:1431316pubmed:pagination369-76lld:pubmed
pubmed-article:1431316pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:1431316pubmed:meshHeadingpubmed-meshheading:1431316-...lld:pubmed
pubmed-article:1431316pubmed:meshHeadingpubmed-meshheading:1431316-...lld:pubmed
pubmed-article:1431316pubmed:meshHeadingpubmed-meshheading:1431316-...lld:pubmed
pubmed-article:1431316pubmed:meshHeadingpubmed-meshheading:1431316-...lld:pubmed
pubmed-article:1431316pubmed:meshHeadingpubmed-meshheading:1431316-...lld:pubmed
pubmed-article:1431316pubmed:meshHeadingpubmed-meshheading:1431316-...lld:pubmed
pubmed-article:1431316pubmed:meshHeadingpubmed-meshheading:1431316-...lld:pubmed
pubmed-article:1431316pubmed:meshHeadingpubmed-meshheading:1431316-...lld:pubmed
pubmed-article:1431316pubmed:meshHeadingpubmed-meshheading:1431316-...lld:pubmed
pubmed-article:1431316pubmed:meshHeadingpubmed-meshheading:1431316-...lld:pubmed
pubmed-article:1431316pubmed:meshHeadingpubmed-meshheading:1431316-...lld:pubmed
pubmed-article:1431316pubmed:meshHeadingpubmed-meshheading:1431316-...lld:pubmed
pubmed-article:1431316pubmed:meshHeadingpubmed-meshheading:1431316-...lld:pubmed
pubmed-article:1431316pubmed:meshHeadingpubmed-meshheading:1431316-...lld:pubmed
pubmed-article:1431316pubmed:meshHeadingpubmed-meshheading:1431316-...lld:pubmed
pubmed-article:1431316pubmed:meshHeadingpubmed-meshheading:1431316-...lld:pubmed
pubmed-article:1431316pubmed:year1992lld:pubmed
pubmed-article:1431316pubmed:articleTitleOpposite sensitivity to the antiproliferative action of interferon-alpha and granulocyte-macrophage colony-stimulating factor in monoblastic U937 cells.lld:pubmed
pubmed-article:1431316pubmed:affiliationDepartment of Internal Medicine (Cancer Research), West German Cancer Center, University of Essen Medical School.lld:pubmed
pubmed-article:1431316pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1431316pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed